About PerHum Therapeutics

About company

Shanghai PerHum Therapeutics is a company focuses on cutting-edge biotechnology, specifically field of adoptive cellular therapies. The core business of the company is to sublicense the CAB-CAR-T technology in Greater China from F1 Oncology. By investing in and building the GMP facility for virus packaging and cell processing related to CAB-CAR-T cell therapy, PerHum Therapeutics Biotechnology supports the CAB-CAR-T clinical trials in solid tumors, cooperating with some of the leading hospitals in China. Shanghai PerHum Therapeutics vision is to overcome the challenge of solid tumors, thereby bringing benefit to society as a whole.